iRadimedvsMerck & Company

IRMD and MRK stock compared: price, dividend, valuation and results, from SEC filings.

IRMD

iRadimed Corporation

$84.84

Value $1.1B

-0.60%
IRMD's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

iRadimed (IRMD) has a market value of $1.1B and Merck & Company (MRK) $357B. Over the last year, with dividends, IRMD moved +2.0% and MRK +60.0%. The P/E is 45.2 for IRMD and 145.6 for MRK. Dividend yield: IRMD 0.94%, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    IRMD$1.1B

    MRK$357B

    MRK is 329 times IRMD

  • Revenue, 12 months

    IRMD$89M

    MRK$67.4B

    MRK is 754 times IRMD

  • Net income, 12 months

    IRMD$24M

    MRK$2.5B

    MRK is 102 times IRMD

  • Operating margin

    IRMD32.3%

    MRK–

  • ROIC

    IRMD22.3%

    MRK3.9%

    18.4 points apart

  • P/E

    IRMD45.2

    MRK145.6

    MRK is 3.2 times IRMD

  • Dividend yield

    IRMD0.9%

    MRK2.4%

    1.5 points apart

  • 5-year return

    IRMD+135.4%

    MRK+101.1%

    34.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

IRMD+135.4%

MRK+101.1%

10020020222023202420252026
Returns by period
PeriodIRMDWith dividendsMRKWith dividends
1 year since November 14, 2025+2.0%Price +0.6%+60.0%Price +55.5%
3 years since November 16, 2023+110.2%+28.1% a yearPrice +100.3%+55.2%+15.8% a yearPrice +41.6%
5 years since November 15, 2021+135.4%+18.7% a yearPrice +113.6%+101.1%+15.0% a yearPrice +72.6%
10 years since November 17, 2016+731.1%+23.6% a yearPrice +654.1%+227.6%+12.6% a yearPrice +141.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

IRMDiRadimedMRKMerck & Company

Valuation

IRMDMRK
Valuation
Price$84.84$144.46
Market value$1.1B$357B
Enterprise value (EV)$1.0B$401B
P/E45.2145.6
P/E, 5-year median36.714.8
P/B10.28.0
EV/EBIT35.484.3
Free cash flow yield2.4%4.1%

Results and growth

IRMDMRK
Results and growth
Revenue, 12 months$89M$67.4B
Net income, 12 months$24M$2.5B
Free cash flow, 12 months$26M$14.7B
Earnings per share, 12 months$1.87$0.98
Revenue growth, year on year14.4%1.3%
Revenue growth a year, past+21.5%over 5 years+9.4%over 5 years
EPS growth a year, past+73.9%over 5 years+21.2%over 5 years

Margins and returns on capital

IRMDMRK
Margins and returns on capital
Gross margin75.5%71.8%
Operating margin32.3%–
Net margin26.9%3.6%
ROIC22.3%3.9%
ROE24.0%5.2%

Balance sheet

IRMDMRK
Balance sheet
Cash$63M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover–2.4×

Dividends and buybacks

IRMDMRK
Dividends and buybacks
Dividend yield0.9%2.4%
Dividend per share, 12 months$0.80$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield0.9%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: IRMD or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, iRadimed or Merck & Company?

By market value, Merck & Company ($357B) is about 329.3 times iRadimed ($1.1B), at today's prices.

How did IRMD and MRK stock do over the last 10 years?

Since November 17, 2016, IRMD's price moved +654.1% and MRK's +141.5%. With dividends: IRMD +731.1% (+23.6% a year), MRK +227.6% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, IRMD or MRK?

The dividend yield at today's price is 0.94% for iRadimed and 2.35% for Merck & Company. Over the last twelve months they paid $0.80 and $3.40 per share.

What is the P/E of IRMD and MRK?

At today's price, the P/E is 45.2 for IRMD and 145.6 for MRK. The median of the last five years was 36.7 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, iRadimed or Merck & Company?

Over the last twelve months, the net margin was 26.9% for iRadimed and 3.6% for Merck & Company, and the operating margin 32.3% and –. Revenue was $89M and $67.4B.

Which is the better investment, iRadimed or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.